Merrill Lynch & Co., Inc. $4,000,000,000 Filed under Rule 424 (b)(3), Registration Statement No. 333-83374 Merill Lynch Notes Due Nine Months Pricing Supplement No. 10007 - dated June 14, 2002 or More from Date of Issue (To prospectus dated April 1, 2002 and prospectus supplement dated April 22, 2002) ==================================================================================================================================== Interest Stated CUSIP Aggregate Price to Purchasing Interest Rate Payment Maturity Survivor's Number Principal Amount Public(1) Agent's Discount(1) Per Annum Frequency Date Option ==================================================================================================================================== 5901M0AQ2 $5,336,000 100.0% 0.6250% 4.20% Monthly 6/20/05 No Redemption Information: N/A - ------------------------------------------------------------------------------------------------------------------------------------ 5901M0AR0 $7,137,000 100.0% 1.0000% 5.00% Monthly 6/19/07 No Redemption Information: N/A - ------------------------------------------------------------------------------------------------------------------------------------ 5901M0AS8 $2,272,000 100.0% 1.2000% 5.45% Monthly 6/19/09 No Redemption Information: Redeemable at the option of Merrill Lynch & Co., Inc. on 6/15/04 and each Interest Payment Date thereafter, at a price equal to 100%. - ------------------------------------------------------------------------------------------------------------------------------------ Trade Date: Friday June 14, 2002 Merrill Lynch & Co. Merrill Lynch & Co., Inc. [LOGO] Issue Date: Wednesday June 19, 2002 Purchasing Agent 4 World Financial Center Minimum Denominations/Increments: $1,000/$1,000 Acting as Principal New York, NY 10080 Original Issue Discount: No All trades settle without accrued interest and clear SDFS: DTC Book-Entry only Merrill Lynch DTC Participant Number: 5132 (1) Expressed as a percentage of the aggregate principal amount. ====================================================================================================================================